Eagle Pharmaceuticals, Inc. (EGRX)

USD 0.65

(0.0%)

Annual Balance Sheets

(In USD)
Breakdown 2022 2021 2020 2019 2018 2017
Total Assets 406.16 Million 253.73 Million 253.19 Million 254.55 Million 238.6 Million 270.06 Million
Total Current Assets 188.75 Million 172.6 Million 166.06 Million 179.44 Million 163.84 Million 188.69 Million
Cash And Short Term Investments 55.32 Million 97.65 Million 103.15 Million 109.77 Million 78.79 Million 114.65 Million
Cash and Cash Equivalents 55.32 Million 97.65 Million 103.15 Million 109.77 Million 78.79 Million 114.65 Million
Short Term Investments - 4.98 Million - - - -
Net Receivables 72.43 Million 41.14 Million 51.11 Million 48 Million 66.48 Million 53.82 Million
Inventory 47.79 Million 21.9 Million 8.07 Million 6.56 Million 8.3 Million 5.11 Million
Other Current Assets 13.2 Million 11.89 Million 1.6 Million 15.1 Million 10.26 Million 15.1 Million
Total Non-Current Assets 217.4 Million 81.12 Million 87.12 Million 75.1 Million 74.75 Million 81.36 Million
Net PPE 1.16 Million 1.63 Million 2.07 Million 2.2 Million 2.39 Million 6.82 Million
Good Will And Intangible Assets 163.36 Million 50.41 Million 52.66 Million 55.32 Million 57.84 Million 63.06 Million
Good Will 45.03 Million 39.74 Million 39.74 Million 39.74 Million 39.74 Million 39.74 Million
Intangible Assets 118.32 Million 10.67 Million 12.91 Million 15.58 Million 18.1 Million 23.32 Million
Long-Term Investments 10.01 Million 6.03 Million 12.2 Million - - -
Tax Assets 27.14 Million 18.79 Million 15.18 Million 13.66 Million 13.82 Million 11.35 Million
Other Non Current Assets 15.72 Million 4.24 Million 5 Million 3.9 Million 694 Thousand 124 Thousand
Other Assets - - - - - -
Total Liabilities 172.6 Million 77.27 Million 67.17 Million 75.38 Million 77.84 Million 90.91 Million
Total Current Liabilities 111.08 Million 74.37 Million 38.08 Million 38.82 Million 39.68 Million 47.3 Million
Account Payables 18.99 Million 16.43 Million 6.26 Million 5.46 Million 9.91 Million 11.98 Million
Tax Payables 5.18 Million - - - - -
Short Term Debt 6.25 Million 25.6 Million 8 Million 5 Million 6.25 Million 4.87 Million
Deferred Revenue - 25.36 Million 20.74 Million 26.06 Million 21.71 Million 15.39 Million
Other Current Liabilities 85.84 Million 6.97 Million 3.07 Million 2.29 Million 1.8 Million 15.05 Million
Total Non Current Liabilities 61.51 Million 2.9 Million 29.09 Million 36.55 Million 38.15 Million 43.61 Million
Long-Term Debt 56.21 Million 2.9 Million 29.09 Million 33.55 Million 38.15 Million 42.9 Million
Deferred Revenue Non Current - -1.75 Million -5.89 Million -1.08 Million - -3.05 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 5.29 Million -1000.00 3.95 Million 3 Million -687 Thousand 709 Thousand
Other Liabilities - - - - - -
Total Equity 233.56 Million 176.45 Million 186.01 Million 179.17 Million 160.76 Million 179.14 Million
Stock Holders Equity 233.56 Million 176.45 Million 186.01 Million 179.17 Million 160.76 Million 179.14 Million
Common Stock 18 Thousand 17 Thousand 17 Thousand 17 Thousand 17 Thousand 16 Thousand
Retained Earnings 111.5 Million 75.86 Million 84.48 Million 72.5 Million 58.18 Million 26.28 Million
Accumulated other comprehensive income -1.11 Million -94 Thousand - - - -
Common Stock Equity 233.56 Million 176.45 Million 186.01 Million 179.17 Million 160.76 Million 179.14 Million
Capital Lease Obligation 1.53 Million 4.21 Million 3.95 Million 3 Million - -
Total Investments 10.01 Million 4.98 Million 12.2 Million - - -
Total Debt 62.46 Million 25.6 Million 37.09 Million 38.55 Million 44.4 Million 47.78 Million
Net Debt 7.14 Million -72.05 Million -66.06 Million -71.21 Million -34.38 Million -66.87 Million

Balance Sheet Charts